Erratum: Functional role of mTORC2 versus integrin-linked kinase in mediating Ser473-Akt phosphorylation in PTEN-Negative prostate and breast cancer cell lines (PLoS ONE (2013) 8, 6 (e67149) DOI: 10.1371/journal.pone.0067149);Functional Role of mTORC2 versus Integrin-Linked Kinase in Mediating Ser473-Akt Phosphorylation in PTEN-Negative Prostate and Breast Cancer Cell Lines

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Lee, Su Lin ^a,c   Chou, Chih Chien ^a   Chuang, Hsiao Ching ^a   Hsu, En Chi ^a   Chiu, Po Chen ^a   Kulp, Samuel K ^a   Byrd, John C ^a   Chen, Ching Shih ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ENZYME; CELL PROTEIN; EPIDERMAL GROWTH FACTOR; INTEGRIN LINKED KINASE; MTOR COMPLEX PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; RICTOR PROTEIN; SERINE; SERINE 473; UNCLASSIFIED DRUG; 5 [2 (2,6 DIMETHYLMORPHOLINO) 4 MORPHOLINOPYRIDO[2,3 D]PYRIMIDIN 7 YL] 2 METHOXYBENZENEMETHANOL; ANILIDE; BENZOIC ACID DERIVATIVE; CARRIER PROTEIN; INTEGRIN-LINKED KINASE; MORPHOLINE DERIVATIVE; MULTIPROTEIN COMPLEX; PROTEIN SERINE THREONINE KINASE; PTEN PROTEIN, HUMAN; PYRIMIDINE DERIVATIVE; RICTOR PROTEIN, HUMAN; T 3157; TARGET OF RAPAMYCIN KINASE; TOR COMPLEX 2;

ARTICLE; BINDING AFFINITY; BINDING SITE; BREAST CANCER; CANCER CELL CULTURE; CELL SPECIFICITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; IMMUNOPRECIPITATION; MOLECULAR DYNAMICS; PHENOTYPE; PROSTATE CANCER; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; UPREGULATION; BREAST TUMOR; CELL SURVIVAL; DEFICIENCY; DRUG EFFECTS; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; PHOSPHORYLATION; PROSTATE TUMOR; TUMOR CELL LINE;

ANILIDES; BENZOATES; BREAST NEOPLASMS; CARRIER PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MORPHOLINES; MULTIPROTEIN COMPLEXES; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; PYRIMIDINES; SERINE; TOR SERINE-THREONINE KINASES; UP-REGULATION;

EID: 84879221780     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0202299     Document Type: Erratum

References (67)

1. Mora A, Komander D, van Aalten DM, Alessi DR, (2004) PDK1, the master regulator of AGC kinase signal transduction. Semin Cell Dev Biol 15: 161-170.
2. Dong LQ, Liu F, (2005) PDK2: the missing piece in the receptor tyrosine kinase signaling pathway puzzle. Am J Physiol Endocrinol Metab 289: E187-196.
3. Hresko RC, Mueckler M, (2005) mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J Biol Chem 280: 40406-40416.
4. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM, (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-1101.
5. Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, et al. (1998) Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci U S A 95: 11211-11216.
6. Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, et al. (2000) Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc Natl Acad Sci U S A 97: 3207-3212.
7. Persad S, Attwell S, Gray V, Mawji N, Deng JT, et al. (2001) Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343. J Biol Chem 276: 27462-27469.
8. Lynch DK, Ellis CA, Edwards PA, Hiles ID, (1999) Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism. Oncogene 18: 8024-8032.
9. Bozulic L, Surucu B, Hynx D, Hemmings BA, (2008) PKBalpha/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival. Mol Cell 30: 203-213.
10. Viniegra JG, Martinez N, Modirassari P, Hernandez Losa J, Parada Cobo C, et al. (2005) Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM. J Biol Chem 280: 4029-4036.
11. Partovian C, Simons M, (2004) Regulation of protein kinase B/Akt activity and Ser473 phosphorylation by protein kinase Calpha in endothelial cells. Cell Signal 16: 951-957.
12. Kawakami Y, Nishimoto H, Kitaura J, Maeda-Yamamoto M, Kato RM, et al. (2004) Protein kinase C betaII regulates Akt phosphorylation on Ser-473 in a cell type- and stimulus-specific fashion. J Biol Chem 279: 47720-47725.
13. Riaz A, Zeller KS, Johansson S, (2012) Receptor-specific mechanisms regulate phosphorylation of AKT at Ser473: role of RICTOR in beta1 integrin-mediated cell survival. PLoS One 7: e32081.
14. Pontier SM, Huck L, White DE, Rayment J, Sanguin-Gendreau V, et al. (2010) Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer. Oncogene 29: 3374-3385.
15. Bravou V, Klironomos G, Papadaki E, Taraviras S, Varakis J, (2006) ILK over-expression in human colon cancer progression correlates with activation of beta-catenin, down-regulation of E-cadherin and activation of the Akt-FKHR pathway. J Pathol 208: 91-99.
16. Chan J, Ko FC, Yeung YS, Ng IO, Yam JW, (2011) Integrin-linked kinase overexpression and its oncogenic role in promoting tumorigenicity of hepatocellular carcinoma. PLoS One 6: e16984.
17. Ahmed N, Riley C, Oliva K, Stutt E, Rice GE, et al. (2003) Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid. J Pathol 201: 229-237.
18. Schaeffer DF, Assi K, Chan K, Buczkowski AK, Chung SW, et al. (2010) Tumor expression of integrin-linked kinase (ILK) correlates with the expression of the E-cadherin repressor snail: an immunohistochemical study in ductal pancreatic adenocarcinoma. Virchows Arch 456: 261-268.
19. Graff JR, Deddens JA, Konicek BW, Colligan BM, Hurst BM, et al. (2001) Integrin-linked kinase expression increases with prostate tumor grade. Clin Cancer Res 7: 1987-1991.
20. Ito R, Oue N, Zhu X, Yoshida K, Nakayama H, et al. (2003) Expression of integrin-linked kinase is closely correlated with invasion and metastasis of gastric carcinoma. Virchows Arch 442: 118-123.
21. Younes MN, Kim S, Yigitbasi OG, Mandal M, Jasser SA, et al. (2005) Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer. Mol Cancer Ther 4: 1146-1156.
22. Troussard AA, Mawji NM, Ong C, Mui A, St-Arnaud R, et al. (2003) Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation. J Biol Chem 278: 22374-22378.
23. Legate KR, Montanez E, Kudlacek O, Fassler R, (2006) ILK, PINCH and parvin: the tIPP of integrin signalling. Nat Rev Mol Cell Biol 7: 20-31.
24. Huang Y, Li J, Zhang Y, Wu C, (2000) The roles of integrin-linked kinase in the regulation of myogenic differentiation. J Cell Biol 150: 861-872.
25. Su JL, Chiou J, Tang CH, Zhao M, Tsai CH, et al. (2010) CYR61 regulates BMP-2-dependent osteoblast differentiation through the {alpha}v{beta}3 integrin/integrin-linked kinase/ERK pathway. J Biol Chem 285: 31325-31336.
26. White DE, Cardiff RD, Dedhar S, Muller WJ, (2001) Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice. Oncogene 20: 7064-7072.
27. Tabe Y, Jin L, Tsutsumi-Ishii Y, Xu Y, McQueen T, et al. (2007) Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells. Cancer Res 67: 684-694.
28. Esfandiarei M, Yazdi SA, Gray V, Dedhar S, van Breemen C, (2010) Integrin-linked kinase functions as a downstream signal of platelet-derived growth factor to regulate actin polymerization and vascular smooth muscle cell migration. BMC Cell Biol 11: 16.
29. Ishii T, Satoh E, Nishimura M, (2001) Integrin-linked kinase controls neurite outgrowth in N1E-115 neuroblastoma cells. J Biol Chem 276: 42994-43003.
30. Leung-Hagesteijn C, Hu MC, Mahendra AS, Hartwig S, Klamut HJ, et al. (2005) Integrin-linked kinase mediates bone morphogenetic protein 7-dependent renal epithelial cell morphogenesis. Mol Cell Biol 25: 3648-3657.
31. Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, et al. (2006) Integrin-linked kinase activity is associated with interleukin-1 alpha-induced progressive behavior of pancreatic cancer and poor patient survival. Oncogene 25: 3237-3246.
32. Kalra J, Sutherland BW, Stratford AL, Dragowska W, Gelmon KA, et al. (2010) Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1. Oncogene 29: 6343-6356.
33. Wickstrom SA, Lange A, Montanez E, Fassler R, (2010) The ILK/PINCH/parvin complex: the kinase is dead, long live the pseudokinase! EMBO J. 29: 281-291.
34. Fukuda K, Knight JD, Piszczek G, Kothary R, Qin J, (2011) Biochemical, proteomic, structural, and thermodynamic characterizations of integrin-linked kinase (ILK): cross-validation of the pseudokinase. J Biol Chem 286: 21886-21895.
35. Grashoff C, Aszodi A, Sakai T, Hunziker EB, Fassler R, (2003) Integrin-linked kinase regulates chondrocyte shape and proliferation. EMBO Rep 4: 432-438.
36. Sakai T, Li S, Docheva D, Grashoff C, Sakai K, et al. (2003) Integrin-linked kinase (ILK) is required for polarizing the epiblast, cell adhesion, and controlling actin accumulation. Genes Dev 17: 926-940.
37. Lorenz K, Grashoff C, Torka R, Sakai T, Langbein L, et al. (2007) Integrin-linked kinase is required for epidermal and hair follicle morphogenesis. J Cell Biol 177: 501-513.
38. Lange A, Wickstrom SA, Jakobson M, Zent R, Sainio K, et al. (2009) Integrin-linked kinase is an adaptor with essential functions during mouse development. Nature 461: 1002-1006.
39. White DE, Coutu P, Shi YF, Tardif JC, Nattel S, et al. (2006) Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failure. Genes Dev 20: 2355-2360.
40. Wang HV, Chang LW, Brixius K, Wickstrom SA, Montanez E, et al. (2008) Integrin-linked kinase stabilizes myotendinous junctions and protects muscle from stress-induced damage. J Cell Biol 180: 1037-1049.
41. Pereira JA, Benninger Y, Baumann R, Goncalves AF, Ozcelik M, et al. (2009) Integrin-linked kinase is required for radial sorting of axons and Schwann cell remyelination in the peripheral nervous system. J Cell Biol 185: 147-161.
42. McDonald PC, Oloumi A, Mills J, Dobreva I, Maidan M, et al. (2008) Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival. Cancer Res 68: 1618-1624.
43. Troussard AA, McDonald PC, Wederell ED, Mawji NM, Filipenko NR, et al. (2006) Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival. Cancer Res 66: 393-403.
44. Edwards LA, Thiessen B, Dragowska WH, Daynard T, Bally MB, et al. (2005) Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth. Oncogene 24: 3596-3605.
45. Younes MN, Yigitbasi OG, Yazici YD, Jasser SA, Bucana CD, et al. (2007) Effects of the integrin-linked kinase inhibitor QLT0267 on squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 133: 15-23.
46. Kalra J, Warburton C, Fang K, Edwards L, Daynard T, et al. (2009) QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model. Breast Cancer Res 11: R25.
47. Eke I, Leonhardt F, Storch K, Hehlgans S, Cordes N, (2009) The small molecule inhibitor QLT0267 Radiosensitizes squamous cell carcinoma cells of the head and neck. PLoS One 4: e6434.
48. Muranyi AL, Dedhar S, Hogge DE, (2009) Combined inhibition of integrin linked kinase and FMS-like tyrosine kinase 3 is cytotoxic to acute myeloid leukemia progenitor cells. Exp Hematol 37: 450-460.
49. Koul D, Shen R, Bergh S, Lu Y, de Groot JF, et al. (2005) Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma. Mol Cancer Ther 4: 1681-1688.
50. Edwards LA, Woo J, Huxham LA, Verreault M, Dragowska WH, et al. (2008) Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of integrin-linked kinase (ILK). Mol Cancer Ther 7: 59-70.
51. Lee SL, Hsu EC, Chou CC, Chuang HC, Bai LY, et al. (2011) Identification and characterization of a novel integrin-linked kinase inhibitor. J Med Chem 54: 6364-6374.
52. Serrano I, McDonald PC, Lock FE, Dedhar S, (2013) Role of the integrin-linked kinase (ILK)/Rictor complex in TGFbeta-1-induced epithelial-mesenchymal transition (EMT). Oncogene 32: 50-60.
53. Debnath J, Muthuswamy SK, Brugge JS, (2003) Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30: 256-268.
54. Garcia-Martinez JM, Moran J, Clarke RG, Gray A, Cosulich SC, et al. (2009) Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR). Biochem J 421: 29-42.
55. Fan QW, Weiss WA, (2011) Autophagy and Akt promote survival in glioma. Autophagy 7: 536-538.
56. Stratford AL, Habibi G, Astanehe A, Jiang H, Hu K, et al. (2007) Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy. Breast Cancer Res 9: R61.
57. Feng J, Park J, Cron P, Hess D, Hemmings BA, (2004) Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase. J Biol Chem 279: 41189-41196.
58. Zhou BP, Deng J, Xia W, Xu J, Li YM, et al. (2004) Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 6: 931-940.
59. Evdokimova V, Tognon C, Ng T, Ruzanov P, Melnyk N, et al. (2009) Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition. Cancer Cell 15: 402-415.
60. Koblinski JE, Kaplan-Singer BR, VanOsdol SJ, Wu M, Engbring JA, et al. (2005) Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis. Cancer Res 65: 7370-7377.
61. Jacobs KM, Bhave SR, Ferraro DJ, Jaboin JJ, Hallahan DE, et al. (2012) GSK-3beta: A Bifunctional Role in Cell Death Pathways. Int J Cell Biol 2012: 930710.
62. Wang L, Lin HK, Hu YC, Xie S, Yang L, et al. (2004) Suppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 beta in prostate cells. J Biol Chem 279: 32444-32452.
63. Lasham A, Samuel W, Cao H, Patel R, Mehta R, et al. (2012) YB-1, the E2F pathway, and regulation of tumor cell growth. J Natl Cancer Inst 104: 133-146.
64. Abboud ER, Coffelt SB, Figueroa YG, Zwezdaryk KJ, Nelson AB, et al. (2007) Integrin-linked kinase: a hypoxia-induced anti-apoptotic factor exploited by cancer cells. Int J Oncol 30: 113-122.
65. Hannigan G, Troussard AA, Dedhar S, (2005) Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev Cancer 5: 51-63.
66. Persad S, Dedhar S, (2003) The role of integrin-linked kinase (ILK) in cancer progression. Cancer Metastasis Rev 22: 375-384.
67. McDonald PC, Fielding AB, Dedhar S, (2008) Integrin-linked kinase - essential roles in physiology and cancer biology. J Cell Sci 121: 3121-3132.